Find a Trial
Trial Summary
| Protocol No. | CTO-208887 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Suvannasankha, Attaya | ||
| Scope | National | ||
| Phase | Phase I/II | ||
| Age Group | Adult | ||
| Title | A Phase I/II Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM5 | ||
| Applicable Disease Sites | Multiple Myeloma | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||